HSBC Holdings’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Buy |
51,822
+16,859
| +48% | +$364K | ﹤0.01% | 1347 |
|
|
2025
Q1 | $841K | Sell |
34,963
-1,374
| -4% | -$33K | ﹤0.01% | 1415 |
|
|
2024
Q4 | $764K | Buy |
36,337
+14,269
| +65% | +$300K | ﹤0.01% | 1576 |
|
|
2024
Q3 | $434K | Sell |
22,068
-10,834
| -33% | -$213K | ﹤0.01% | 1733 |
|
|
2024
Q2 | $504K | Buy |
32,902
+20,543
| +166% | +$315K | ﹤0.01% | 1622 |
|
|
2024
Q1 | $197K | Buy |
+12,359
| New | +$197K | ﹤0.01% | 2283 |
|
|
2023
Q1 | – | Sell |
-20,969
| Closed | -$385K | – | 2272 |
|
|
2022
Q4 | $385K | Buy |
20,969
+3,013
| +17% | +$55.3K | ﹤0.01% | 1958 |
|
|
2022
Q3 | $232K | Buy |
+17,956
| New | +$232K | ﹤0.01% | 2124 |
|